Luc Djoussé1, I-Min Lee, Julie E Buring, J Michael Gaziano. 1. Division of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA. ldjousse@rics.bwh.harvard.edu
Abstract
BACKGROUND: Although an association between moderate alcohol consumption and decreased cardiovascular disease (CVD) and death has been reported, limited data are available on potential mediating mechanisms. We examined the association between alcohol and CVD and death in 26 399 women and estimated the proportion of reduced risk of CVD/death explained by a series of intermediate factors. METHODS AND RESULTS: Alcohol consumption was self-reported at baseline, and CVD events and deaths were ascertained via follow-up questionnaires and medical records. Baseline levels of hemoglobin A1c, inflammatory markers, hemostatic factors, and lipids were measured. Blood pressure and hypercholesterolemia and treatment for lipids were self-reported. During a mean follow up of 12.2 years, 1039 CVD events and 785 deaths (153 CVD deaths) occurred. There was a J-shaped relation between alcohol consumption and incident CVD and total and CVD deaths in a multivariable model. Compared with abstainers, alcohol intake of 5 to 14.9 g/d was associated with 26%, 35%, and 51% lower risk of CVD, total death, and CVD death, respectively, in a multivariable model. For CVD risk reduction, lipids made the largest contribution to the lower risk of CVD (28.7%), followed by hemoglobin A1c/diabetes (25.3%), inflammatory/hemostatic factors (5%), and blood pressure factors (4.6%). All these mediating factors together explained 86.3%, 18.7%, and 21.8% of the observed lower risk of CVD, total death, and CVD death, respectively. CONCLUSIONS: These data suggest that alcohol effects on lipids and insulin sensitivity may account for a large proportion of the lower risk of CVD/death observed with moderate drinking under the assumption that the alcohol-CVD association is causal.
RCT Entities:
BACKGROUND: Although an association between moderate alcohol consumption and decreased cardiovascular disease (CVD) and death has been reported, limited data are available on potential mediating mechanisms. We examined the association between alcohol and CVD and death in 26 399 women and estimated the proportion of reduced risk of CVD/death explained by a series of intermediate factors. METHODS AND RESULTS:Alcohol consumption was self-reported at baseline, and CVD events and deaths were ascertained via follow-up questionnaires and medical records. Baseline levels of hemoglobin A1c, inflammatory markers, hemostatic factors, and lipids were measured. Blood pressure and hypercholesterolemia and treatment for lipids were self-reported. During a mean follow up of 12.2 years, 1039 CVD events and 785 deaths (153 CVD deaths) occurred. There was a J-shaped relation between alcohol consumption and incident CVD and total and CVD deaths in a multivariable model. Compared with abstainers, alcohol intake of 5 to 14.9 g/d was associated with 26%, 35%, and 51% lower risk of CVD, total death, and CVD death, respectively, in a multivariable model. For CVD risk reduction, lipids made the largest contribution to the lower risk of CVD (28.7%), followed by hemoglobin A1c/diabetes (25.3%), inflammatory/hemostatic factors (5%), and blood pressure factors (4.6%). All these mediating factors together explained 86.3%, 18.7%, and 21.8% of the observed lower risk of CVD, total death, and CVD death, respectively. CONCLUSIONS: These data suggest that alcohol effects on lipids and insulin sensitivity may account for a large proportion of the lower risk of CVD/death observed with moderate drinking under the assumption that the alcohol-CVD association is causal.
Authors: M S van der Gaag; A Sierksma; G Schaafsma; A van Tol; T Geelhoed-Mieras; M Bakker; H F Hendriks Journal: J Womens Health Gend Based Med Date: 2000 Jul-Aug
Authors: K J Mukamal; P P Jadhav; R B D'Agostino; J M Massaro; M A Mittleman; I Lipinska; P A Sutherland; T Matheney; D Levy; P W Wilson; R C Ellison; H Silbershatz; J E Muller; G H Tofler Journal: Circulation Date: 2001-09-18 Impact factor: 29.690
Authors: Michael J Davies; David J Baer; Joseph T Judd; Ellen D Brown; William S Campbell; Philip R Taylor Journal: JAMA Date: 2002-05-15 Impact factor: 56.272
Authors: Lindsay M Squeglia; Jeff Boissoneault; Candice E Van Skike; Sara Jo Nixon; Douglas B Matthews Journal: Alcohol Clin Exp Res Date: 2014-08-25 Impact factor: 3.455
Authors: Nina P Paynter; Michael J LaMonte; JoAnn E Manson; Lisa W Martin; Lawrence S Phillips; Paul M Ridker; Jennifer G Robinson; Nancy R Cook Journal: Circulation Date: 2014-08-25 Impact factor: 29.690
Authors: Senthil Selvaraj; Sanjiv J Shah; Mark J Ommerborn; Cheryl R Clark; Michael E Hall; Robert J Mentz; Saadia Qazi; Jeremy M Robbins; Thomas N Skelton; Jiaying Chen; J Michael Gaziano; Luc Djoussé Journal: Circ Heart Fail Date: 2017-06 Impact factor: 8.790
Authors: Shun Kohsaka; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio Journal: Atherosclerosis Date: 2011-08-16 Impact factor: 5.162
Authors: Helena C Parkington; Kelly R Kenna; Foula Sozo; Harold A Coleman; Alan Bocking; James F Brien; Richard Harding; David W Walker; Ruth Morley; Marianne Tare Journal: J Physiol Date: 2014-04-22 Impact factor: 5.182
Authors: Eric J Shiroma; Nancy R Cook; Joann E Manson; M V Moorthy; Julie E Buring; Eric B Rimm; I-Min Lee Journal: Med Sci Sports Exerc Date: 2017-01 Impact factor: 5.411
Authors: Eric W Klee; Henning Schneider; Karl J Clark; Margot A Cousin; Jon O Ebbert; W Michael Hooten; Victor M Karpyak; David O Warner; Stephen C Ekker Journal: Hum Genet Date: 2011-12-30 Impact factor: 4.132